Rapid Antigen Testing Market - Top Companies and Manufacturers

  • Report ID: 5849
  • Published Date: Nov 27, 2024
  • Report Format: PDF, PPT

Companies Dominating the Rapid Antigen Testing Landscape

    • iHealth Labs, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • NeoDx Biotech Labs
    • Abbott Laboratories
    • Affinity Biologics, Inc.
    • Siemens Healthineers AG
    • Epitope Diagnostics, Inc.
    • Sino Biological, Inc.
    • R-Biopharma AG
    • Cell Biolabs, Inc.
    • Thermo Fisher Scientific

Browse Key Market Insights with Data Illustration:

In the News

  • iHealth Labs, Inc., a digital health startup and the United States' leading provider of at-home COVID tests, launched its Home Collection Kit for syphilis and HIV testing. Anyone over the age of 18 can use the FDA-approved method to take a blood sample in the privacy of their own home to test for syphilis and HIV (I, II, P24 antigen). They can mail the sample to the lab with a pre-paid overnight label and obtain accurate, private results in as little as two days.
  • NeoDx Biotech Labs, a Bengaluru-based business, has introduced an in vitro diagnostic (IVD) kit for Ankylosing Spondylitis that uses real-time PCR technology. This kit enables healthcare services to enhance their testing capabilities. The HLA-B27 RT-PCR detection kit for Exon 2/Exon 3 is a real-time PCR test kit that is used to identify Human Leukocyte Antigen B27 in whole blood. HLA-B27 has a strong correlation with the inflammatory conditions of Ankylosing Spondylitis (AS), Psoriasis, Inflammatory Bowel Disease, and Reactive Arthritis. HLA-B27 testing can help in the early diagnosis and treatment of various conditions.

Author Credits:  Radhika Pawar


  • Report ID: 5849
  • Published Date: Nov 27, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of rapid antigen testing is assessed at USD 27.2 billion.

The rapid antigen testing market size was over USD 25.68 billion in 2024 and is projected to reach USD 64.96 billion by 2037, growing at around 7.4% CAGR during the forecast period i.e., between 2025-2037. The growing adoption of rapid antigen tests for diagnosis of other viral infections, the growing shift towards digitalization in the healthcare industry, and growing incidences of infectious diseases will boost the market growth.

North America industry is anticipated to hold largest revenue share of 37% by 2037, due to increasing prevalence of antibiotic-resistant infections and respiratory illnesses in the region.

The major players in the market are iHealth Labs, Inc., NeoDx Biotech Labs, Abbott Laboratories, Affinity Biologics, Inc., Siemens Healthineers AG, Epitope Diagnostics, Inc., Sino Biological, Inc., R-Biopharma AG, Cell Biolabs, Inc, Thermo Fisher Scientific, Kaneka Corporation, FUJIFILM Corporation, Otsuka Pharmaceutical Co., Ltd., Hitachi, Ltd., Shionogi & Co., Ltd. and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample